183 related articles for article (PubMed ID: 30885098)
21. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
[TBL] [Abstract][Full Text] [Related]
22. Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.
Stock W; Johnson JL; Stone RM; Kolitz JE; Powell BL; Wetzler M; Westervelt P; Marcucci G; DeAngelo DJ; Vardiman JW; McDonnell D; Mrózek K; Bloomfield CD; Larson RA
Cancer; 2013 Jan; 119(1):90-8. PubMed ID: 22744771
[TBL] [Abstract][Full Text] [Related]
23. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
Tubergen DG; Gilchrist GS; O'Brien RT; Coccia PF; Sather HN; Waskerwitz MJ; Hammond GD
J Clin Oncol; 1993 Mar; 11(3):520-6. PubMed ID: 8445427
[TBL] [Abstract][Full Text] [Related]
24. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
25. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia.
Pui CH; Mahmoud HH; Rivera GK; Hancock ML; Sandlund JT; Behm FG; Head DR; Relling MV; Ribeiro RC; Rubnitz JE; Kun LE; Evans WE
Blood; 1998 Jul; 92(2):411-5. PubMed ID: 9657739
[TBL] [Abstract][Full Text] [Related]
26. Identifying causes of variability in outcomes in children with acute lymphoblastic leukemia treated in a resource-rich developing country.
Jastaniah W; Elimam N; Abdalla K; Iqbal BA; Khattab TM; Felimban S; Abrar MB
Pediatr Blood Cancer; 2015 Jun; 62(6):945-50. PubMed ID: 25557583
[TBL] [Abstract][Full Text] [Related]
27. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
Ribeiro RC; Rivera GK; Hudson M; Mulhern RK; Hancock ML; Kun L; Mahmoud H; Sandlund JT; Crist WM; Pui CH
J Clin Oncol; 1995 Feb; 13(2):333-8. PubMed ID: 7844594
[TBL] [Abstract][Full Text] [Related]
28. CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials.
Clarke M; Gaynon P; Hann I; Harrison G; Masera G; Peto R; Richards S;
J Clin Oncol; 2003 May; 21(9):1798-809. PubMed ID: 12721257
[TBL] [Abstract][Full Text] [Related]
29. Treatment of acute lymphoblastic leukemia in Hong Kong children: HKALL 93 study.
Li CK; Chik KW; Chan GC; Yuen HL; Lee AC; Li CK; Shing MM; Ha SY; Luk CW; Ling SC; Cheung AY;
Hematol Oncol; 2003 Mar; 21(1):1-9. PubMed ID: 12605417
[TBL] [Abstract][Full Text] [Related]
30. Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985.
Gelber RD; Sallan SE; Cohen HJ; Donnelly M; Dalton V; Tobia F; Clavell LA; Tarbell NJ
Cancer; 1993 Jul; 72(1):261-70. PubMed ID: 8508416
[TBL] [Abstract][Full Text] [Related]
31. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
[TBL] [Abstract][Full Text] [Related]
32. Treatment of childhood acute lymphoblastic leukemia with delayed first intrathecal therapy and omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002 study.
Yeh TC; Liang DC; Hou JY; Jaing TH; Lin DT; Yang CP; Peng CT; Hung IJ; Lin KH; Hsiao CC; Jou ST; Chiou SS; Chen JS; Wang SC; Chang TK; Wu KH; Sheen JM; Yen HJ; Chen SH; Lu MY; Li MJ; Chang TT; Huang TH; Chang YH; Chen SH; Yang YL; Chang HH; Chen BW; Lin PC; Cheng CN; Chao YH; Yang SH; Chao YY; Liu HC
Cancer; 2018 Dec; 124(23):4538-4547. PubMed ID: 30303520
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic significance of cerebrospinal fluid flow cytometry in Chinese children with B lineage acute lymphoblastic leukemia.
Tang X; Mai H; Wang L; Chen S; Chen F; Li T; Liu Y; Zhou G; Liu S; Wang Y; Liu S; Fu X; Wen F
BMC Pediatr; 2024 Mar; 24(1):204. PubMed ID: 38519960
[TBL] [Abstract][Full Text] [Related]
34. Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia.
Perruso LL; Velloso E; Rocha V; Rego EM; Silva WF
Ann Hematol; 2024 Jun; 103(6):2033-2039. PubMed ID: 38180535
[TBL] [Abstract][Full Text] [Related]
35. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Pullen J; Boyett J; Shuster J; Crist W; Land V; Frankel L; Iyer R; Backstrom L; van Eys J; Harris M
J Clin Oncol; 1993 May; 11(5):839-49. PubMed ID: 8487048
[TBL] [Abstract][Full Text] [Related]
36. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .
Ritchey AK; Pollock BH; Lauer SJ; Andejeski Y; Barredo J; Buchanan GR
J Clin Oncol; 1999 Dec; 17(12):3745-52. PubMed ID: 10577846
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience.
Abbott BL; Rubnitz JE; Tong X; Srivastava DK; Pui CH; Ribeiro RC; Razzouk BI
Leukemia; 2003 Nov; 17(11):2090-6. PubMed ID: 14523477
[TBL] [Abstract][Full Text] [Related]
38. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
Pediatr Blood Cancer; 2010 Sep; 55(3):414-20. PubMed ID: 20658610
[TBL] [Abstract][Full Text] [Related]
39. Central nervous system involvement at presentation in childhood acute lymphoblastic leukemia: management experience and lessons.
Marwaha RK; Kulkarni KP; Bansal D; Trehan A
Leuk Lymphoma; 2010 Feb; 51(2):261-8. PubMed ID: 20038226
[TBL] [Abstract][Full Text] [Related]
40. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.
Tubergen DG; Gilchrist GS; O'Brien RT; Coccia PF; Sather HN; Waskerwitz MJ; Hammond GD
J Clin Oncol; 1993 Mar; 11(3):527-37. PubMed ID: 8445428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
